Library — CHDR

Search

Filter

Ketamine effects on resting state functional brain connectivity in major depressive disorder patients: a hypothesis-driven analysis based on a network model of depression.

Recourt K, Van Gerven J, Drenth N, van der Grond J, Nishigori K, Van Der Wee NJ, Jacobs GE

Frontiers in neuroscience, 2025 Feb

View publication
CB Receptor Antagonist Selonabant (ANEB-001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled Trial.

Gorbenko AA, Heuberger JAAC, Juachon M, Klaassen E, Tagen M, Lawler JF, Schneeberger D, Cundy KC, Klumpers LE, Groeneveld GJ

Clinical pharmacology and therapeutics, 2025 Feb

View publication
Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.

Otto ME, van der Heijden KV, Schoones JW, van Esdonk MJ, Borghans LGJM, Jacobs GE, van Hasselt CJG

Clinical pharmacokinetics, 2025 Jan

View publication
Cardiac inotropy and cardiac calcium sensitization of PanLN800(-Forte), a cationic heptamethine indocyanine fluorescent contrast agent for intraoperative pan lymph node imaging.

Faber RA, Baart VM, Bordo MW, March TL, Valentijn ARPM, Harmsen S, Pool M, Burggraaf J, Frangioni JV, Vahrmeijer AL

Toxicology and applied pharmacology, 2024 Dec

View publication
Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study.

Janus A, Dumas D, Le Douce J, Marie S, Pasculli G, Bambury P, Lemarchant S, Kremer P, Godfrin Y

Neurology and therapy, 2024 Dec

View publication
Safety, Pharmacokinetics, and Pharmacodynamics of a First-in-Class ClC-1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial.

Ruijs TQ, de Cuba CMKE, Heuberger JAAC, Hutchison J, Bold J, Grønnebæk TS, Jensen KG, Chin E, Quiroz JA, Petersen TK, Flagstad P, de Kam ML, van Esdonk MJ, Klaassen E, Doll RJ, Koopmans IW, de Goede AA, Aulin LBS, Pedersen TH, Groeneveld GJ

Clinical pharmacology and therapeutics, 2024 Dec

View publication
TMS and EEG Pharmacodynamic Effects of a Selective Sphingosine-1-Phosphate Subtype 1 Receptor Agonist on Cortical Excitability in Healthy Subjects.

de Cuba CMKE, de Goede AA, Klaassen ES, Otto ME, Doll RJ, Kim J, Demitrack MA, Chen R, Groeneveld GJ, Heuberger JAAC

Clinical pharmacology and therapeutics, 2024 Dec

View publication
Remote Patient Monitoring Using Mobile Health Technology in Cancer Care and Research: Patients' Views and Preferences.

Stuijt DG, van Doeveren EEM, Kos M, Eversdijk M, Bosch JJ, Bins AD, Bak MAR, van Oijen MGH

JCO clinical cancer informatics, 2024 Nov

View publication
Cognitive Effects of Three β-Adrenoceptor Acting Drugs in Healthy Volunteers and Patients with Parkinson's Disease.

Eijsvogel PPNM, Borghans LGJM, Prins S, Moss L, van Kraaij SJW, van Brummelen E, Klaassen E, Martin RS, Bautista E, Ford AP, Kremer PHC, Groeneveld GJ, Vargas GA

Journal of Parkinson's disease, 2024 Oct; 14(6):1149-1161

View publication

«
1
2
3
4
5
6
7
8
...
99
100
»